Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic profile of advanced breast cancer in circulating tumour DNA.
Kingston B, Cutts RJ, Bye H, Beaney M, Walsh-Crestani G, Hrebien S, Swift C, Kilburn LS, Kernaghan S, Moretti L, Wilkinson K, Wardley AM, Macpherson IR, Baird RD, Roylance R, Reis-Filho JS, Hubank M, Faull I, Banks KC, Lanman RB, Garcia-Murillas I, Bliss JM, Ring A, Turner NC. Kingston B, et al. Among authors: moretti l. Nat Commun. 2021 Apr 23;12(1):2423. doi: 10.1038/s41467-021-22605-2. Nat Commun. 2021. PMID: 33893289 Free PMC article.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Turner NC, Kingston B, Kilburn LS, Kernaghan S, Wardley AM, Macpherson IR, Baird RD, Roylance R, Stephens P, Oikonomidou O, Braybrooke JP, Tuthill M, Abraham J, Winter MC, Bye H, Hubank M, Gevensleben H, Cutts R, Snowdon C, Rea D, Cameron D, Shaaban A, Randle K, Martin S, Wilkinson K, Moretti L, Bliss JM, Ring A. Turner NC, et al. Among authors: moretti l. Lancet Oncol. 2020 Oct;21(10):1296-1308. doi: 10.1016/S1470-2045(20)30444-7. Epub 2020 Sep 10. Lancet Oncol. 2020. PMID: 32919527 Free PMC article. Clinical Trial.
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.
Kingston B, Cutts RJ, Bye H, Beaney M, Walsh-Crestani G, Hrebien S, Swift C, Kilburn LS, Kernaghan S, Moretti L, Wilkinson K, Wardley AM, Macpherson IR, Baird RD, Roylance R, Reis-Filho JS, Hubank M, Faull I, Banks KC, Lanman RB, Garcia-Murillas I, Bliss JM, Ring A, Turner NC. Kingston B, et al. Among authors: moretti l. Nat Commun. 2021 Jul 16;12(1):4479. doi: 10.1038/s41467-021-24791-5. Nat Commun. 2021. PMID: 34272402 Free PMC article. No abstract available.
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).
Ring A, Kilburn LS, Pearson A, Moretti L, Afshari-Mehr A, Wardley AM, Gurel B, Macpherson IR, Riisnaes R, Baird RD, Martin S, Roylance R, Johnson H, Ferreira A, Winter MC, Dunne K, Copson E, Hickish T, Burcombe R, Randle K, Serra V, Llop-Guevara A, Bliss JM, Turner NC. Ring A, et al. Among authors: moretti l. Clin Cancer Res. 2023 Dec 1;29(23):4751-4759. doi: 10.1158/1078-0432.CCR-23-1696. Clin Cancer Res. 2023. PMID: 37773077 Free PMC article. Clinical Trial.
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer.
Kingston B, Pearson A, Herrera-Abreu MT, Sim LX, Cutts RJ, Shah H, Moretti L, Kilburn LS, Johnson H, Macpherson IR, Ring A, Bliss JM, Hou Y, Toy W, Katzenellenbogen JA, Chandarlapaty S, Turner NC. Kingston B, et al. Among authors: moretti l. Cancer Discov. 2024 Feb 8;14(2):274-289. doi: 10.1158/2159-8290.CD-22-1387. Cancer Discov. 2024. PMID: 37982575 Free PMC article.
Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.
Batten LM, Bhattacharya IS, Moretti L, Haviland JS, Emson MA, Miller SE, Jefford M, MacKenzie M, Wilcox M, Hyslop M, Todd R, Snowdon CF, Bliss JM. Batten LM, et al. Among authors: moretti l. Res Involv Engagem. 2018 Jul 16;4:22. doi: 10.1186/s40900-018-0108-0. eCollection 2018. Res Involv Engagem. 2018. PMID: 30026963 Free PMC article.
National prospective cohort study of the burden of acute small bowel obstruction.
Lee MJ, Sayers AE, Drake TM, Marriott PJ, Anderson ID, Bach SP, Bradburn M, Hind D, Verjee A, Fearnhead NS; NASBO steering group and NASBO collaborators. Lee MJ, et al. BJS Open. 2019 Feb 22;3(3):354-366. doi: 10.1002/bjs5.50136. eCollection 2019 Jun. BJS Open. 2019. PMID: 31183452 Free PMC article.
Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction.
National Audit of Small Bowel Obstruction Steering Group & National Audit of Small Bowel Obstruction Collaborators. National Audit of Small Bowel Obstruction Steering Group & National Audit of Small Bowel Obstruction Collaborators. Eur J Surg Oncol. 2019 Dec;45(12):2319-2324. doi: 10.1016/j.ejso.2019.07.014. Epub 2019 Jul 9. Eur J Surg Oncol. 2019. PMID: 31378418 Free article.
Outcomes of obstructed abdominal wall hernia: results from the UK national small bowel obstruction audit.
National Audit of Small Bowel Obstruction Steering Group and National Audit of Small Bowel Obstruction Collaborators; NASBO Steering Group; NASBO Collaborators; West Midlands Research Collaborative. National Audit of Small Bowel Obstruction Steering Group and National Audit of Small Bowel Obstruction Collaborators, et al. BJS Open. 2020 Oct;4(5):924-934. doi: 10.1002/bjs5.50315. Epub 2020 Jul 10. BJS Open. 2020. PMID: 32648645 Free PMC article.
523 results